How has JNJ's R&D spending evolved over the past two years?

Johnson & Johnson's (JNJ) Research and Development (R&D) spending has demonstrated a consistent upward trajectory over the past two years, with a cumulative total of $17.44 billion invested in 2024. This represents a significant commitment to innovation and underscores the company's focus on developing new products and technologies to maintain its position in the highly competitive pharmaceutical industry. |code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code| |---|---|---|---|---|---|---| |JNJ|JNJ.N|Johnson & Johnson|2023 Q1|3.504E9|-13.948919449901767|169| |JNJ|JNJ.N|Johnson & Johnson|2023 Q2|3.703E9|0|169| |JNJ|JNJ.N|Johnson & Johnson|2023 Q3|3.653E9|4.820659971305596|169| |JNJ|JNJ.N|Johnson & Johnson|2023 Q4|4.538E9|16.868400721091938|169| |JNJ|JNJ.N|Johnson & Johnson|2024 Q1|3.542E9|1.0844748858447488|169| |JNJ|JNJ.N|Johnson & Johnson|2024 Q2|3.634E9|-1.8633540372670807|169| |JNJ|JNJ.N|Johnson & Johnson|2024 Q3|4.952E9|35.559813851628796|169| |JNJ|JNJ.N|Johnson & Johnson|2024 Q4|5.315E9|17.122080211546937|169|